adalimumab,methotrexate
abbvie
['adalimumab', 'methotrexate', 'rheumatoid,arthritis']
we would think that targeted therapies would have reduced gc use in ra. well, this is not really the case. comaprison of gc use in 1999-2008 vs. 2009-2018
52% of patients remain on gc for&gt;3mo after initiation &amp; 1/3 still continues after 2 years! #eular23 pos0309 
MD, PhD @UofGlasgow UK. Chair of EULAR live course subcommittee. Past Co-chair @EULAR Synovitis Study Group. CrossFit athlete and Mountains lover. Views my own.